Empire Genomics | Clinical FISH Probe Panels

SEARCH OUR PRODUCT CATALOG

As of August 11th, Empire is operating as an essential New York State business and has no production or shipping delays

FISH Probe PANELS

Making New Disease Specific Discoveries


Empire Genomics FISH probe panels are designed to hybridize to the precise location of genes associated with a specific disease and contain multiple RP11 clones to produce a strong signal. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads. Disease specific probes are available in both single and dual colors. These products are for research use only (RUO) and are not for use in diagnostic procedures.

AneuFocus

Our AneuFocus kit is used to identify chromosome 13, 18, 21, X and Y aneusomy, which collectively account for the vast majority of clinically significant karyotype alterations in both prenatal cases and newborns.

View Biomarkers

FGFR Panel

FGFR 1, 2, 3 and 4 are tyrosine kinase receptors involved in numerous intracellular signaling pathways. FGFR alterations promote disease progression in several different cancers. Our FGFR panel offers probes for detecting these abnormalities.

View Biomarkers

Multiple Myeloma

Multiple myeloma is the end result of several precursor conditions that are triggered by abnormal proliferation of plasma cells. Patients can display a diverse array of genetic alterations, which have been shown to correlate with different disease stages.

View Biomarkers

NTRK Probes

The NTRK gene family encodes receptors that regulate multiple pathways crucial to nervous system development. NTRK fusions, which generate chimeric proteins with unchecked NTRK signaling, have emerged as disease drivers across a range of cancers.

View Biomarkers

PDL FISH Probes

Malignant cells have been shown to overexpress PD-L1 and PD-L2 receptors on their surface in order to escape T-cell destruction. Our PD-L FISH panel offers probes to detect PD-L1 and PD-L2 gene amplification.

View Biomarkers

Pediatric Brain Cancer

Pediatric cancer is often aggressive and has a high mortality rate. Among childhood cancers, pediatric brain tumors are the most common cause of death. The 2 major fusion types identified in pediatric brain cancer, RELA fusions and YAP1 fusions, have opposite clinical implications. Determining which of these mutations is present...

View Biomarkers

Renal Cell Carcinoma

Renal cell carcinoma (RCC) is the most frequently diagnosed kidney cancer. The disease is clinically and genetically heterogeneous, with a diverse range of subtypes that all stem from abnormal cell proliferation in the tubule linings of the kidneys. A variety of genes have been implicated in RCC oncogenesis. Empire Genomics'...

View Biomarkers